Arifulla Khan
Psychiatry · Bellevue, WANPI 1134241888
Payments from drug & device makers
Across 2,304 payments — averaging $15,444 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$19.6M
- AbbVie$4.4M
- Sage Therapeutics, LLC$1.8M
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1.6M
- Pfizer$996K
- Alkermes, Inc.$969K
- plus $6.2M from 30 others
Across 58 payments — averaging $5438.28 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$158K
- Pfizer$152K
- Eli Lilly Export S.A. Puerto Rico Branch$5K
- Corcept Therapeutics$595
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$35,582,169 in reported general payments places this provider in the 95th percentile of 576 psychiatry providers in Washington.
Other psychiatry in Bellevue
- Arun AroraBellevue$10.6M
- Aishwarya PrasadBellevue$323K
- Maryann BolteBellevue$4K
- Deborah HaynesBellevue$2K
- Jeffrey HansenVancouver$2.8M
- Chester RobachinskiSeattle$1.1M
- Larry BornsteinEverett$663K
- David DunnerMercer Island$649K
- Matthew BogoyasYakima$500K
- Shirin SchillingEverett$263K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.